Arvee Laboratories (India) Past Earnings Performance
Past criteria checks 2/6
Arvee Laboratories (India) has been growing earnings at an average annual rate of 1.7%, while the Chemicals industry saw earnings growing at 16% annually. Revenues have been declining at an average rate of 2.4% per year. Arvee Laboratories (India)'s return on equity is 3.6%, and it has net margins of 3.5%.
Key information
1.7%
Earnings growth rate
-0.4%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | -2.4% |
| Return on equity | 3.6% |
| Net Margin | 3.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today
Aug 08
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching
Apr 13Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?
Dec 22We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease
Sep 16Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price
Aug 13Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)
Apr 19Revenue & Expenses Breakdown
How Arvee Laboratories (India) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 303 | 11 | 39 | 0 |
| 31 Dec 23 | 284 | 9 | 45 | 0 |
| 30 Sep 23 | 369 | 16 | 51 | 0 |
| 30 Jun 23 | 519 | 35 | 62 | 0 |
| 31 Mar 23 | 613 | 41 | 62 | 0 |
| 31 Dec 22 | 698 | 49 | 58 | 0 |
| 30 Sep 22 | 615 | 45 | 57 | 0 |
| 30 Jun 22 | 494 | 32 | 57 | 0 |
| 31 Mar 22 | 400 | 26 | 57 | 0 |
| 31 Dec 21 | 369 | 22 | 42 | 0 |
| 30 Sep 21 | 489 | 32 | 43 | 0 |
| 30 Jun 21 | 477 | 27 | 34 | 0 |
| 31 Mar 21 | 474 | 27 | 56 | 0 |
| 31 Dec 20 | 475 | 28 | 24 | 0 |
| 30 Sep 20 | 369 | 17 | 37 | 0 |
| 30 Jun 20 | 407 | 21 | 74 | 0 |
| 31 Mar 20 | 454 | 23 | 28 | 0 |
| 31 Dec 19 | 478 | 25 | 62 | 0 |
| 30 Sep 19 | 501 | 27 | 54 | 0 |
| 30 Jun 19 | 525 | 25 | 55 | 0 |
| 31 Mar 19 | 549 | 23 | 55 | 0 |
| 30 Jun 18 | 549 | 14 | 64 | 0 |
| 31 Mar 18 | 478 | 11 | 62 | 0 |
| 31 Mar 17 | 344 | 16 | 33 | 0 |
| 31 Mar 16 | 268 | 2 | 26 | 0 |
| 31 Mar 15 | 130 | -16 | 19 | 0 |
| 31 Mar 14 | 118 | 0 | 8 | 0 |
Quality Earnings: ARVEE has high quality earnings.
Growing Profit Margin: ARVEE's current net profit margins (3.5%) are lower than last year (6.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARVEE's earnings have grown by 1.7% per year over the past 5 years.
Accelerating Growth: ARVEE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ARVEE had negative earnings growth (-74.5%) over the past year, making it difficult to compare to the Chemicals industry average (-0.2%).
Return on Equity
High ROE: ARVEE's Return on Equity (3.6%) is considered low.